OTCM
UEEC
Market cap13mUSD
Jul 09, Last price
0.05USD
1D
-13.22%
1Q
8.39%
IPO
-94.11%
Name
United Health Products Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Henderson, Nevada, United Health Products, Inc., established in 1997, focuses on the creation, production, and distribution of hemostatic gauze solutions throughout the United States. This company primarily caters to the healthcare and wound management industries. Its prominent offering, HemoStyp hemostatic gauze, is engineered to manage bleeding and absorb fluids from superficial injuries. The firm serves a broad spectrum of clients, including hospitals, surgical facilities, medical clinics, military healthcare providers, hemodialysis centers, assisted living and nursing homes, and veterinary hospitals. Additionally, their products are utilized by emergency medical services (EMS), fire departments, various other first responders, and dental, oral, and maxillofacial surgery practices. The company adopted its current name in September 2010, having previously operated as United EcoEnergy Corp.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||